[1]顾而立, 姚光弼.中国人原发性胆汁性肝硬化的临床特点:52年文献的系统分析[J].中华肝脏病杂志, 2009, 17 (11) :861-866.
|
[2]任慧琼, 彭国林, 邹晓平, 等.78例原发性胆汁性肝硬化的临床分析[J].肝脏, 2006, 11 (1) :33-35.
|
[3]Heathcote EJ.Management of primary biliary cirrhosis:The American Association for the Study of Liver Diseases practice guideline[J].J Hepatol, 2000, 4 (31) :1005-1013.
|
[4] 陆再英, 钟南山, 谢毅, 等.内科学第7版[M].北京:人民卫生出版社, 2008:779.
|
[5]张霞, 沈鼎明.肝源性糖尿病的研究进展[J].中华肝脏病杂志, 2002, 10 (6) :476-47.
|
[6]Nakasone H, Kinjo K, Yamashiro M.A Patient with primary biliary cirrhosis complicated with slowly progressive insulin-dependent diabetes mellitus[J].Intern Med, 2003, 6 (42) :496-499.
|
[7]Kisand KE, Metskula K, Kisand KV, et al.The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples[J].J Gastroenterol, 200l, 4 (36) :248-254.
|
[1] | Xiwang WANG, Jingjing JIN, Ying WANG, Chenxiao WANG, Yonghua ZHANG, Yajiao GU, Xiao WANG. Pathogenesis, diagnosis, and treatment of pancreatogenic diabetes[J]. Journal of Clinical Hepatology, 2024, 40(5): 1068-1072. doi: 10.12449/JCH240532 |
[2] | Ruibin WANG, Yuzheng LU, Jinglin ZHU, Wei WANG, Guang JIA. Inhibitory effect of lidocaine on Kupffer cell inflammatory response and its effect on liver abscess formation in diabetic mice[J]. Journal of Clinical Hepatology, 2022, 38(6): 1341-1346. doi: 10.3969/j.issn.1001-5256.2022.06.023 |
[3] | Deyun WANG, Ruirui JIN, Zhen ZHAO, Hui LI. Brain abscess secondary to liver abscess in type 2 diabetes mellitus: A case report[J]. Journal of Clinical Hepatology, 2022, 38(6): 1375-1376. doi: 10.3969/j.issn.1001-5256.2022.06.031 |
[4] | Changqing ZHAO. Integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis with diabetes[J]. Journal of Clinical Hepatology, 2022, 38(9): 1980-1985. doi: 10.3969/j.issn.1001-5256.2022.09.006 |
[5] | Zhao Juan, Hui Wei, Dou AiHua, Wei LinLin, Liu Mei, Dong GuiFang, Xu Bin. A clinical analysis of hypoglycemia in patients with liver cirrhosis and diabetes mellitus[J]. Journal of Clinical Hepatology, 2020, 36(2): 329-332. doi: 10.3969/j.issn.1001-5256.2020.02.019 |
[6] | Zhang YongChao, Li Wei. Association between diabetes and nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(10): 2329-2332. doi: 10.3969/j.issn.1001-5256.2020.10.037 |
[7] | Wang WeiZhao, Zhu QinLing, Xiang XiaoXing, Ma Li, Ju MengXian, Jin XiaoLong, Wang YongChao, Han WeiWei, Xu QingCheng. Clinical features of diabetic patients with bacterial liver abscess and different levels of glycosylated hemoglobin[J]. Journal of Clinical Hepatology, 2019, 35(11): 2537-2541. doi: 10.3969/j.issn.1001-5256.2019.11.029 |
[8] | Zhang ShuZe, Wang KeShen, Ren YanXian, Yu ZeYuan, Yang HanTeng, Jiao ZuoYi. Clostridium perfringens liver abscess in patients with diabetes mellitus: A case report[J]. Journal of Clinical Hepatology, 2018, 34(9): 1979-1981. doi: 10.3969/j.issn.1001-5256.2018.09.030 |
[9] | Yang Shuo, Jiang XiaoDi. Clinical effect of linagliptin combined with insulin aspart 50 in treatment of hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2017, 33(5): 928-931. doi: 10.3969/j.issn.1001-5256.2017.05.028 |
[10] | Liang Jing, Han Tao. Diabetes mellitus and primary liver cancer: risk factor or real cause?[J]. Journal of Clinical Hepatology, 2017, 33(4): 757-762. doi: 10.3969/j.issn.1001-5256.2017.04.037 |
[11] | Wang LiFeng, Li YuanYuan, Jin Lei, Wang FuSheng. Epidemiology and natural history of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 165-170. doi: 10.3969/j.issn.1001-5256.2015.02.005 |
[12] | Liu HongXia, Cheng Min, Wang XiMing, Lei Ding. Clinical effect of combination therapy with NovoRapid 30 and modified Yinchenhao decoction in treatment of chronic hepatitis B with diabetes[J]. Journal of Clinical Hepatology, 2014, 30(4): 311-313. doi: 10.3969/j.issn.1001-5256.2014.04.006 |
[13] | Hui Wei, Xu Bin, Guo XinHui. Clinical study on glucose metabolic disorder in patients with diabetes and chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(7): 538-541. |
[14] | Zhao ZhangQing, Gu HongTu, Xing Feng, Zhou Yang, Xu LieMing. Clinical features of post-hepatitis B liver cirrhosis associated with diabetes mellitus[J]. Journal of Clinical Hepatology, 2012, 28(6): 450-455. |
[15] | Zhang FengChun. Primary biliary cirrhosis and liver disease secondary to diffuse connective tissue diseases[J]. Journal of Clinical Hepatology, 2011, 27(6): 588-590. |
[16] | Yu MingXia, Yin WeiMin, Li YingJin, Wu Yang. The treatment status of hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2011, 27(7): 779-782. |
[20] | Qin YingFen, Xian Su, Wei MinYi, Luo ZuoJie, Chen QingYun, Wang NaiZun. Changes of hepatic ultrastructure in patients with diabetes mellitus[J]. Journal of Clinical Hepatology, 2000, 16(4): 241-243. |